129
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinical Significance of Fibrinogen and Platelet to Pre-Albumin Ratio in Predicting the Prognosis of Advanced Gastric Cancer

, , , ORCID Icon, , , ORCID Icon & show all
Pages 4373-4388 | Received 11 Mar 2023, Accepted 13 Jun 2023, Published online: 02 Oct 2023

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
  • Balakrishnan M, George R, Sharma A, et al. Changing trends in stomach cancer throughout the world. Curr Gastroenterol Rep. 2017;19(8):36. doi:10.1007/s11894-017-0575-8
  • Spolverato G, Capelli G, Lorenzoni G, et al. Development of a prognostic nomogram and nomogram software application tool to predict overall survival and disease-free survival after curative-intent gastrectomy for gastric cancer. Ann Surg Oncol. 2022;29(2):1220–1229. doi:10.1245/s10434-021-10768-7
  • Chiang CY, Huang KH, Fang WL, et al. Factors associated with recurrence within 2 years after curative surgery for gastric adenocarcinoma. World J Surg. 2011;35(11):2472–2478. doi:10.1007/s00268-011-1247-8
  • Choi Y, Kim JW, Nam KH, et al. Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer. Gastric Cancer. 2017;20(4):602–611. doi:10.1007/s10120-016-0642-0
  • Kim EY, Song KY. The preoperative and the postoperative neutrophil-to-lymphocyte ratios both predict prognosis in gastric cancer patients. World J Surg Oncol. 2020;18(1):293. doi:10.1186/s12957-020-02059-4
  • Miyamoto R, Inagawa S, Sano N, et al. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients. Eur J Surg Oncol. 2018;44(5):607–612. doi:10.1016/j.ejso.2018.02.003
  • Gu X, Gao XS, Cui M, et al. Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer. Oncotarget. 2016;7(31):49878–49887. doi:10.18632/oncotarget.10490
  • Chen L, Chen Y, Zhang L, et al. In gastric cancer patients receiving neoadjuvant chemotherapy systemic inflammation response index is a useful prognostic indicator. Pathol Oncol Res. 2021;27:1609811. doi:10.3389/pore.2021.1609811
  • Xin Y, Zhang X, Li Y, et al. A Systemic Inflammation Response Index (SIRI)-based nomogram for predicting the recurrence of early stage hepatocellular carcinoma after radiofrequency ablation. Cardiovasc Intervent Radiol. 2022;45(1):43–53. doi:10.1007/s00270-021-02965-4
  • Pacheco-Barcia V, Mondejar SR, France T, et al. A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer. Pancreatology. 2020;20(2):254–264. doi:10.1016/j.pan.2019.12.010
  • Ding P, Zheng C, Cao G, et al. Combination of preoperative plasma fibrinogen and AJCC staging improves the accuracy of survival prediction for patients with stage I-II gastric cancer after curative gastrectomy. Cancer Med. 2019;8(6):2919–2929. doi:10.1002/cam4.2086
  • Zhang L, Qin S, Lu L, et al. Diagnostic value of combined prealbumin-to-fibrinogen and albumin-to-fibrinogen ratios in Hp-negative gastric cancer. Int J Biol Markers. 2022;37(1):66–73. doi:10.1177/17246008211072875
  • Wang J, Zhang M, Zhou T, et al. Role of platelet infiltration as independent prognostic marker for gastric adenocarcinomas. J Clin Lab Anal. 2020;34(8):e23320. doi:10.1002/jcla.23320
  • Kuroda D, Sawayama H, Kurashige J, et al. Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer. 2018;21(2):204–212. doi:10.1007/s10120-017-0744-3
  • Fu X, Yang Y, Zhang D. Molecular mechanism of albumin in suppressing invasion and metastasis of hepatocellular carcinoma. Liver Int. 2022;42(3):696–709. doi:10.1111/liv.15115
  • Palumbo JS, Kombrinck KW, Drew AF, et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood. 2000;96(10):3302–3309. doi:10.1182/blood.V96.10.3302
  • Yu W, Wang Y, Shen B. An elevated preoperative plasma fibrinogen level is associated with poor overall survival in Chinese gastric cancer patients. Cancer Epidemiol. 2016;42:39–45. doi:10.1016/j.canep.2016.03.004
  • Sun DW, An L, Lv GY. Albumin-fibrinogen ratio and fibrinogen-prealbumin ratio as promising prognostic markers for cancers: an updated meta-analysis. World J Surg Oncol. 2020;18(1):9. doi:10.1186/s12957-020-1786-2
  • Lin JX, Desiderio J, Lin JP, et al. Multicenter validation study of the American joint commission on cancer (8th Edition) for gastric cancer: proposal for a simplified and improved TNM staging system. J Cancer. 2020;11(12):3483–3491. doi:10.7150/jca.36891
  • Wang FH, Zhang XT, Li YF, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun. 2021;41(8):747–795. doi:10.1002/cac2.12193
  • Du S, Fang Z, Ye L, et al. Pretreatment neutrophil-to-lymphocyte ratio predicts the benefit of gastric cancer patients with systemic therapy. Aging. 2021;13(13):17638–17654. doi:10.18632/aging.203256
  • Zhu Z, Gao J, Liu Z, et al. Preoperative Platelet-to-Lymphocyte Ratio (PLR) for predicting the survival of stage I-III gastric cancer patients with a MGC component. Biomed Res Int. 2021;2021:9678363. doi:10.1155/2021/9678363
  • Sharma BK, Mureb D, Murab S, et al. Fibrinogen activates focal adhesion kinase (FAK) promoting colorectal adenocarcinoma growth. J Thromb Haemost. 2021;19(10):2480–2494. doi:10.1111/jth.15440
  • Kwaan HC, Lindholm PF. Fibrin and fibrinolysis in cancer. Semin Thromb Hemost. 2019;45(4):413–422. doi:10.1055/s-0039-1688495
  • Kovalski JR, Kuzuoglu-Ozturk D, Ruggero D. Protein synthesis control in cancer: selectivity and therapeutic targeting. EMBO J. 2022;41(8):e109823. doi:10.15252/embj.2021109823
  • Liu ZJ, Ge XL, Ai SC, et al. Postoperative decrease of serum albumin predicts short-term complications in patients undergoing gastric cancer resection. World J Gastroenterol. 2017;23(27):4978–4985. doi:10.3748/wjg.v23.i27.4978
  • Lu J, Xu BB, Zheng CH, et al. Development and external validation of a nomogram to predict recurrence-free survival after R0 resection for stage II/III gastric cancer: an international multicenter study. Front Oncol. 2020;10:574611. doi:10.3389/fonc.2020.574611
  • Bando E, Makuuchi R, Irino T, et al. Validation of the prognostic impact of the new tumor-node-metastasis clinical staging in patients with gastric cancer. Gastric Cancer. 2019;22(1):123–129. doi:10.1007/s10120-018-0799-9
  • Cheng X, Yu S, Wang Y, et al. The role of oxaliplatin in the adjuvant setting of different Lauren’s type of gastric adenocarcinoma after D2 gastrectomy: a real-world study. Gastric Cancer. 2019;22(3):587–597. doi:10.1007/s10120-018-0895-x
  • Kim JW, Cho SY, Chae J, et al. Adjuvant chemotherapy in microsatellite instability-high gastric cancer. Cancer Res Treat. 2020;52(4):1178–1187. doi:10.4143/crt.2020.313
  • Zhang Z, Rousson V, Lee WC, et al. Decision curve analysis: a technical note. Ann Transl Med. 2018;6(15):308. doi:10.21037/atm.2018.07.02
  • Vickers AJ, Holland F. Decision curve analysis to evaluate the clinical benefit of prediction models. Spine J. 2021;21(10):1643–1648. doi:10.1016/j.spinee.2021.02.024